<!DOCTYPE html>
<html>
    <head>
        <title>STD Tx Guidelines</title>
    </head>
    <body>
        <!-- Start of page -->
        <div data-role="page" id="g146" data-theme="a">
            <div data-role="header" data-id="guidelines-header" data-theme="b" data-position="fixed">
                <a href="lv-142.html" class="ui-btn ui-icon-back ui-btn-icon-notext ui-corner-all" aria-label="back"></a>
                <h3>STD Tx Guidelines</h3>
	<a href="../menu.html" class="ui-btn ui-icon-grid ui-btn-icon-notext ui-corner-all" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-47.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-87.html" >Diseases Characterized by Genital, Anal, or Perianal Ulcers</a><span class="carrot"> > </span>
                    <a href="lv-87.html" >Syphilis</a><span class="carrot"> > </span>
                    <a href="lv-127.html" >Syphilis Among HIV-Infected Persons</a><span class="carrot"> > </span>
                    <a href="lv-142.html" >Neurosyphilis Among HIV-Infected Persons</a><span class="carrot"> > </span>Special Considerations
            </div>
            </br><h5 class="sgc-1 sgc-1" id="sigil_toc_id_146">
 Special Considerations
</h5>
<p>
 <b>
  Penicillin
 </b>
 &nbsp;
 <b>
  Allergy
 </b>
 . HIV-infected, penicillin-allergic patients who have neurosyphilis should be managed according to the recommendations for penicillin-allergic, HIV-negative patients with neurosyphilis. Several small observational studies conducted in HIV-infected patients with neurosyphilis suggest that ceftriaxone 1&ndash;2 g IV daily for 10-14 days might be effective as an alternate agent (218,229,230).&nbsp;
</p>

            </div>
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>

